AKT1 and neoplasm: Furthermore, PI3K/AKT signaling directly regulated glucose transporter 4 and glucose metabolic enzymes [45, 46], therefore, combined PI3K and CD36 inhibitors might restrict the energy supply for tumor growth by synergistically reducing exogenous FAs and glucose resources.